Ares Capital Corp <ARCC.O>: Truist Securities cuts target price to $21 from $22
ARCC•Related News
United Therapeutics CEO Martine Rothblatt disposes of common shares worth $4.96 million
UTHR•
Cincinnati Financial Corporation <CINF.O>: BofA Global Research Cuts to Neutral From Buy Rating
CINF•
Evommune starts Phase 2b trial of EVO756 for migraine prevention
EVMN•
Hirtle Callaghan publishes 2Q 2026 Investment Perspective excerpt
QQQ•
Federal Signal Q2 FY26 GAAP diluted EPS rises 21% to $1.40; net sales increase 19% to $670 million
FSS•